Differential regulation of CIDEA and CIDEC expression by insulin via Akt1/2- and JNK2-dependent pathways in human adipocytes

Journal of Lipid Research

Volumn 52, Issue 8, 2011, Pages 1450-1460

  Ito, Minoru ^a   Nagasawa, Michiaki ^a   Omae, Naoki ^a   Ide, Tomohiro ^a   Akasaka, Yunike ^a   Murakami, Koji ^a  

^a KYORIN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Apoptosis; c Jun N terminal kinase; Cell death inducing DNA fragmentation factor like effector; Lipid droplet formation; Phosphatidylinositol 3 kinase; Small interfering RNA

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (4 HYDROXYPHENYL) 4 MORPHOLINOPYRIDO[3',2':4,5]FURO[3,2 D]PYRIMIDINE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; AGENTS AFFECTING LIPID METABOLISM; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; API 2; CELL DEATH INDUCING DNA FRAGMENTATION FACTOR ALPHA LIKE EFFECTOR PROTEIN A; CELL DEATH INDUCING DNA FRAGMENTATION FACTOR ALPHA LIKE EFFECTOR PROTEIN C; FAT DROPLET; INSULIN; PROTEIN JNK1; PROTEIN JNK2; PROTEIN KINASE B; PROTEIN KINASE B BETA; PROTEIN KINASE B INHIBITOR; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; WORTMANNIN;

ADIPOCYTE; ADULT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; LIPID ANALYSIS; LIPOGENESIS; PRIORITY JOURNAL; PROTEIN DEPLETION; SIGNAL TRANSDUCTION; UPREGULATION;

ADIPOCYTES; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CHLORPROPAMIDE; DNA FRAGMENTATION; DOWN-REGULATION; FEMALE; FURANS; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; INSULIN; MITOGEN-ACTIVATED PROTEIN KINASE 9; OBESITY; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PYRIDINES; PYRIMIDINES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 79960665256     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M012427     Document Type: Article

References (56)

1. Haslam, D. W., and W. P. James. 2005. Obesity. Lancet. 366: 1197-1209.
2. Hirsch, J., and B. Batchelor. 1976. Adipose tissue cellularity in human obesity. Clin. Endocrinol. Metab. 5: 299-311.
3. Sakai, T., H. Sakaue, T. Nakamura, M. Okada, Y. Matsuki, E. Watanabe, R. Hiramatsu, K. Nakayama, K. I. Nakayama, and M. Kasuga. 2007. Skp2 controls adipocyte proliferation during the development of obesity. J. Biol. Chem. 282: 2038-2046. (Pubitemid 47076733)
4. Despres, J. P., and I. Lemieux. 2006. Abdominal obesity and metabolic syndrome. Nature. 444: 881-887. (Pubitemid 46024995)
5. Rosen, E. D., and B. M. Spiegelman. 2006. Adipocytes as regulators of energy balance and glucose homeostasis. Nature. 444: 847-853.
6. Prins, J. B., and S. O'Rahilly. 1997. Regulation of adipose cell number in man. Clin. Sci. (Lond.). 92: 3-11. (Pubitemid 27033005)
7. Urso, B., C. U. Niesler, S. O'Rahilly, and K. Siddle. 2001. Comparison of anti-apoptotic signalling by the insulin receptor and IGF-I receptor in preadipocytes and adipocytes. Cell. Signal. 13: 279-285. (Pubitemid 32295947)
8. Qian, H., D. B. Hausman, M. M. Compton, R. J. Martin, M. A. Della-Fera, D. L. Hartzell, and C. A. Baile. 2001. TNFalpha induces and insulin inhibits caspase 3-dependent adipocyte apoptosis. Biochem. Biophys. Res. Commun. 284: 1176-1183.
9. Kahn, B. B., and J. S. Flier. 2000. Obesity and insulin resistance. J. Clin. Invest. 106: 473-481.
10. Kersten, S. 2001. Mechanisms of nutritional and hormonal regulation of lipogenesis. EMBO Rep. 2: 282-286. (Pubitemid 32401521)
11. Thorne, A., F. Lonnqvist, J. Apelman, G. Hellers, and P. Arner. 2002. A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int. J. Obes. Relat. Metab. Disord. 26: 193-199. (Pubitemid 34151196)
12. Loftus, T. M., F. P. Kuhajda, and M. D. Lane. 1998. Insulin depletion leads to adipose-specific cell death in obese but not lean mice. Proc. Natl. Acad. Sci. USA. 95: 14168-14172.
13. Bluher, M., M. D. Michael, O. D. Peroni, K. Ueki, N. Carter, B. B. Kahn, and C. R. Kahn. 2002. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev. Cell. 3: 25-38.
14. Taniguchi, C. M., B. Emanuelli, and C. R. Kahn. 2006. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 7: 85-96.
15. Manning, B. D., and L. C. Cantley. 2007. AKT/PKB signaling: navigating downstream. Cell. 129: 1261-1274.
16. Brodbeck, D., P. Cron, and B. A. Hemmings. 1999. A human protein kinase Bgamma with regulatory phosphorylation sites in the activation loop and in the C-terminal hydrophobic domain. J. Biol. Chem. 274: 9133-9136.
17. Cho, H., J. Mu, J. K. Kim, J. L. Thorvaldsen, Q. Chu, E. B. Crenshaw 3rd, K. H. Kaestner, M. S. Bartolomei, G. I. Shulman, and M. J. Birnbaum. 2001. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science. 292: 1728-1731.
18. Cho, H., J. L. Thorvaldsen, Q. Chu, F. Feng, and M. J. Birnbaum. 2001. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem. 276: 38349-38352.
19. Tschopp, O., Z. Z. Yang, D. Brodbeck, B. A. Dummler, M. Hemmings-Mieszczak, T. Watanabe, T. Michaelis, J. Frahm, and B. A. Hemmings. 2005. Essential role of protein kinase B gamma (PKB gamma/Akt3) in postnatal brain development but not in glucose homeostasis. Development. 132: 2943-2954.
20. Juntilla, M. M., J. A. Wofford, M. J. Birnbaum, J. C. Rathmell, and G. A. Koretzky. 2007. Akt1 and Akt2 are required for alphabeta thymocyte survival and differentiation. Proc. Natl. Acad. Sci. USA. 104: 12105-12110.
21. Liu, X., Y. Shi, M. J. Birnbaum, K. Ye, R. De Jong, T. Oltersdorf, V. L. Giranda, and Y. Luo. 2006. Quantitative analysis of anti-apoptotic function of Akt in Akt1 and Akt2 double knock-out mouse embryonic fibroblast cells under normal and stressed conditions. J. Biol. Chem. 281: 31380-31388.
22. Carlson, C. J., S. Koterski, R. J. Sciotti, G. B. Poccard, and C. M. Rondinone. 2003. Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression. Diabetes. 52: 634-641.
23. Bost, F., M. Aouadi, L. Caron, P. Even, N. Belmonte, M. Prot, C. Dani, P. Hofman, G. Pages, J. Pouyssegur, et al. 2005. The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes. 54: 402-411.
24. Hirosumi, J., G. Tuncman, L. Chang, C. Z. Gorgun, K. T. Uysal, K. Maeda, M. Karin, and G. S. Hotamisligil. 2002. A central role for JNK in obesity and insulin resistance. Nature. 420: 333-336.
25. Tuncman, G., J. Hirosumi, G. Solinas, L. Chang, M. Karin, and G. S. Hotamisligil. 2006. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc. Natl. Acad. Sci. USA. 103: 10741-10746.
26. Koistinen, H. A., A. V. Chibalin, and J. R. Zierath. 2003. Aberrant p38 mitogen-activated protein kinase signalling in skeletal muscle from Type 2 diabetic patients. Diabetologia. 46: 1324-1328.
27. Davis, R. J. 2000. Signal transduction by the JNK group of MAP kinases. Cell. 103: 239-252.
28. Yang, D. D., C. Y. Kuan, A. J. Whitmarsh, M. Rincon, T. S. Zheng, R. J. Davis, P. Rakic, and R. A. Flavell. 1997. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature. 389: 865-870.
29. Minden, A., A. Lin, F. X. Claret, A. Abo, and M. Karin. 1995. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell. 81: 1147-1157.
30. Xia, Z., M. Dickens, J. Raingeaud, R. J. Davis, and M. E. Greenberg. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270: 1326-1331.
31. Rozo, A. V., R. Vijayvargia, H. R. Weiss, and H. Ruan. 2008. Silencing Jnk1 and Jnk2 accelerates basal lipolysis and promotes fatty acid reesterification in mouse adipocytes. Diabetologia. 51: 1493-1504.
32. Inohara, N., T. Koseki, S. Chen, X. Wu, and G. Nunez. 1998. CIDE, a novel family of cell death activators with homology to the 45 kDa subunit of the DNA fragmentation factor. EMBO J. 17: 2526-2533. (Pubitemid 28221188)
33. Liang, L., M. Zhao, Z. Xu, K. K. Yokoyama, and T. Li. 2003. Molecular cloning and characterization of CIDE-3, a novel member of the cell-death-inducing DNA-fragmentation-factor (DFF45)-like effector family. Biochem. J. 370: 195-203. (Pubitemid 36259432)
34. Zhou, Z., S. Yon Toh, Z. Chen, K. Guo, C. P. Ng, S. Ponniah, S. C. Lin, W. Hong, and P. Li. 2003. Cidea-deficient mice have lean phenotype and are resistant to obesity. Nat. Genet. 35: 49-56. (Pubitemid 37048595)
35. Li, J. Z., J. Ye, B. Xue, J. Qi, J. Zhang, Z. Zhou, Q. Li, Z. Wen, and P. Li. 2007. Cideb regulates diet-induced obesity, liver steatosis, and insulin sensitivity by controlling lipogenesis and fatty acid oxidation. Diabetes. 56: 2523-2532. (Pubitemid 47523259)
36. Nishino, N., Y. Tamori, S. Tateya, T. Kawaguchi, T. Shibakusa, W. Mizunoya, K. Inoue, R. Kitazawa, S. Kitazawa, Y. Matsuki, et al. 2008. FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets. J. Clin. Invest. 118: 2808-2821.
37. Toh, S. Y., J. Gong, G. Du, J. Z. Li, S. Yang, J. Ye, H. Yao, Y. Zhang, B. Xue, Q. Li, et al. 2008. Up-regulation of mitochondrial activity and acquirement of brown adipose tissue-like property in the white adipose tissue of fsp27 deficient mice. PLoS ONE. 3: e2890.
38. Nordstrom, E. A., M. Ryden, E. C. Backlund, I. Dahlman, M. Kaaman, L. Blomqvist, B. Cannon, J. Nedergaard, and P. Arner. 2005. A human-specific role of cell death-inducing DFFA (DNA fragmentation factor-alpha)-like effector A (CIDEA) in adipocyte lipolysis and obesity. Diabetes. 54: 1726-1734. (Pubitemid 40770763)
39. Gummesson, A., M. Jernas, P. A. Svensson, I. Larsson, C. A. Glad, E. Schele, L. Gripeteg, K. Sjoholm, T. C. Lystig, L. Sjostrom, et al. 2007. Relations of adipose tissue CIDEA gene expression to basal metabolic rate, energy restriction, and obesity: population-based and dietary intervention studies. J. Clin. Endocrinol. Metab. 92: 4759-4765. (Pubitemid 350223457)
40. Dahlman, I., M. Kaaman, H. Jiao, J. Kere, M. Laakso, and P. Arner. 2005. The CIDEA gene V115F polymorphism is associated with obesity in Swedish subjects. Diabetes. 54: 3032-3034. (Pubitemid 41401104)
41. Zhang, L., K. Miyaki, T. Nakayama, and M. Muramatsu. 2008. Cell death-inducing DNA fragmentation factor alpha-like effector A (CIDEA) gene V115F (G→T) polymorphism is associated with phenotypes of metabolic syndrome in Japanese men. Metabolism. 57: 502-505. (Pubitemid 351317964)
42. Rubio-Cabezas, O., V. Puri, I. Murano, V. Saudek, R. K. Semple, S. Dash, C. S. Hyden, W. Bottomley, C. Vigouroux, J. Magre, et al. 2009. Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC. EMBO Mol. Med. 1: 280-287.
43. Puri, V., S. Konda, S. Ranjit, M. Aouadi, A. Chawla, M. Chouinard, A. Chakladar, and M. P. Czech. 2007. Fat-specific protein 27, a novel lipid droplet protein that enhances triglyceride storage. J. Biol. Chem. 282: 34213-34218.
44. Keller, P., J. T. Petrie, P. De Rose, I. Gerin, W. S. Wright, S. H. Chiang, A. R. Nielsen, C. P. Fischer, B. K. Pedersen, and O. A. Macdougald. 2008. Fat-specific protein 27 regulates storage of triacylglycerol. J. Biol. Chem. 283: 14355-14365.
45. Ito, M., M. Nagasawa, T. Hara, T. Ide, and K. Murakami. 2010. Differential roles of CIDEA and CIDEC in insulin-induced antiapoptosis and lipid droplet formation in human adipocytes. J. Lipid Res. 51: 1676-1684.
46. Yang, L., H. C. Dan, M. Sun, Q. Liu, X. M. Sun, R. I. Feldman, A. D. Hamilton, M. Polokoff, S. V. Nicosia, M. Herlyn, et al. 2004. Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt. Cancer Res. 64: 4394-4399. (Pubitemid 38856907)
47. Kim, J. Y., K. Liu, S. Zhou, K. Tillison, Y. Wu, and C. M. Smas. 2008. Assessment of fat-specific protein 27 in the adipocyte lineage suggests a dual role for FSP27 in adipocyte metabolism and cell death. Am. J. Physiol. Endocrinol. Metab. 294: E654-E667.
48. Reusch, J. E., and D. J. Klemm. 2002. Inhibition of cAMP-response element-binding protein activity decreases protein kinase B/Akt expression in 3T3-L1 adipocytes and induces apoptosis. J. Biol. Chem. 277: 1426-1432.
49. Bennett, B. L., D. T. Sasaki, B. W. Murray, E. C. O'Leary, S. T. Sakata, W. Xu, J. C. Leisten, A. Motiwala, S. Pierce, Y. Satoh, et al. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA. 98: 13681-13686. (Pubitemid 33115958)
50. Grimard, V., J. Massier, D. Richter, D. Schwudke, Y. Kalaidzidis, E. Fava, A. Hermetter, and C. Thiele. 2008. siRNA screening reveals JNK2 as an evolutionary conserved regulator of triglyceride homeostasis. J. Lipid Res. 49: 2427-2440.
51. Choi, S. M., D. F. Tucker, D. N. Gross, R. M. Easton, L. M. DiPilato, A. S. Dean, B. R. Monks, and M. J. Birnbaum. 2010. Insulin regulates adipocyte lipolysis via an Akt-independent signaling pathway. Mol. Cell. Biol. 30: 5009-5020.
52. McTernan, P. G., A. L. Harte, L. A. Anderson, A. Green, S. A. Smith, J. C. Holder, A. H. Barnett, M. C. Eggo, and S. Kumar. 2002. Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro. Diabetes. 51: 1493-1498. (Pubitemid 34826616)
53. Nian, Z., Z. Sun, L. Yu, S. Y. Toh, J. Sang, and P. Li. 2010. Fatspecific protein 27 undergoes ubiquitin-dependent degradation regulated by triacylglycerol synthesis and lipid droplet formation. J. Biol. Chem. 285: 9604-9615.
54. Desbois-Mouthon, C., M. J. Blivet-Van Eggelpoel, M. Auclair, G. Cherqui, J. Capeau, and M. Caron. 1998. Insulin differentially regulates SAPKs/JNKs and ERKs in CHO cells overexpressing human insulin receptors. Biochem. Biophys. Res. Commun. 243: 765-770. (Pubitemid 28414154)
55. Lee, Y. H., J. Giraud, R. J. Davis, and M. F. White. 2003. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J. Biol. Chem. 278: 2896-2902.
56. Hotamisligil, G. S. 2005. Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes. Diabetes. 54 (Suppl. 2): S73-S78. (Pubitemid 43343334)